Expert Review of Anticancer Therapy, Volume 17, Issue 2 (2017)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Review of Anticancer Therapy, Volume 17, Issue 2 (2017)

See all volumes and issues
Vol 24, 2024 Vol 23, 2023 Vol 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Volume 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Editorial

Editorial
On-treatment biomarkers in metastatic renal cell carcinoma: towards individualization of prognosis?
Frede Donskov, Daniel Y C Heng & Brian I Rini
Pages: 97-99
Published online: 20 Dec 2016
First Page PreviewforOn-treatment biomarkers in metastatic renal cell carcinoma: towards individualization of prognosis? | Full Text | References | PDF (298.3 KB)
  • 1121 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access

Perspective

Article
Radical cystectomy: do we need standardization?
Christian Ladurner, Evi Comploj, Emanuela Trenti, Salvatore Palermo, Alexander Pycha & Armin Pycha
Pages: 101-107
Published online: 28 Dec 2016
AbstractforRadical cystectomy: do we need standardization? | Full Text | References | PDF (567.6 KB)
  • 88 Views
  • 1 CrossRef citations
  • 0Altmetric

Review

Review
Endocrine therapy in epithelial ovarian cancer
Simon P Langdon, Charlie Gourley, Hani Gabra & Barbara Stanley
Pages: 109-117
Published online: 24 Dec 2016
AbstractforEndocrine therapy in epithelial ovarian cancer | Full Text | References | PDF (703.3 KB)
  • 809 Views
  • 34 CrossRef citations
  • 0Altmetric
Review
Intra-arterial therapies for liver cancer: assessing tumor response
Yasmin W. Stroehl, Brian S. Letzen, Johanna M. M. van Breugel, Jean-Francois Geschwind & Julius Chapiro
Pages: 119-127
Published online: 27 Dec 2016
AbstractforIntra-arterial therapies for liver cancer: assessing tumor response | Full Text | References | PDF (922 KB)
  • 507 Views
  • 9 CrossRef citations
  • 0Altmetric
Review
Sunitinib in kidney cancer: 10 years of experience and development
Elise Nassif, Constance Thibault, Yann Vano, Laure Fournier, Laetitia Mauge, Virginie Verkarre, Marc-Olivier Timsit, Arnaud Mejean, Eric Tartour & Stéphane Oudard
Pages: 129-142
Published online: 27 Dec 2016
AbstractforSunitinib in kidney cancer: 10 years of experience and development | Full Text | References | PDF (1.4 MB)
  • 526 Views
  • 24 CrossRef citations
  • 0Altmetric
Review
Advanced non-small cell lung cancer (NSCLC) with activating EGFR mutations: first-line treatment with afatinib and other EGFR TKIs
Wolfgang Brückl, Amanda Tufman & Rudolf Maria Huber
Pages: 143-155
Published online: 12 Dec 2016
AbstractforAdvanced non-small cell lung cancer (NSCLC) with activating EGFR mutations: first-line treatment with afatinib and other EGFR TKIs | Full Text | References | PDF (1.4 MB)
  • 464 Views
  • 19 CrossRef citations
  • 0Altmetric
Review
From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage?
Filippo Alongi, Stefano Arcangeli, Sara Ramella, Niccolò Giaj-Levra, Paolo Borghetti, Rolando D’angelillo, Francesco Ricchetti, Marta Maddalo, Rosario Mazzola, Marco Trovò, Elvio Russi, Stefano Maria Magrini & on the behalf of Associazione Italiana Radioterapia Oncologica (AIRO)
Pages: 157-165
Published online: 05 Jan 2017
AbstractforFrom chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage? | Full Text | References | PDF (702.2 KB)
  • 188 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
Time-to-event endpoints in operable non-small-cell lung cancer randomized clinical trials
Frédéric Fiteni, Marie-Justine Paillard, Virginie Westeel & Franck Bonnetain
Pages: 167-173
Published online: 23 Dec 2016
AbstractforTime-to-event endpoints in operable non-small-cell lung cancer randomized clinical trials | Full Text | References | PDF (551.8 KB)
  • 116 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
Cancer immunotherapy: activating innate and adaptive immunity through CD40 agonists
Gregory L. Beatty, Yan Li & Kristen B. Long
Pages: 175-186
Published online: 14 Dec 2016
AbstractforCancer immunotherapy: activating innate and adaptive immunity through CD40 agonists | Full Text | References | PDF (1 MB)
  • 1312 Views
  • 89 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Targeted therapies in advanced biliary malignancies: a clinical review
Udhayvir S Grewal et al.
Review Article | Published online: 31 Jul 2024
Immune-related adverse events associated with mogamulizumab: a comprehensive review of the literature
Genevieve S. Silva et al.
Review Article | Published online: 23 Jul 2024
Bevacizumab-containing treatment for relapsed or refractory Wilms tumor
Sarah Al-Jilaihawi et al.
Review Article | Published online: 23 Jul 2024
UNDERSTANDING the LINK BETWEEN ASPARTAME and CANCER
Morando Soffritti
Report | Published online: 23 Jul 2024
View all latest articles